Answers are grounded in this paper and cite their sources.
Shorter duration therapy for hepatitis C virus (HCV) infection might reduce treatment costs and increase the number of patients treated and cured. We determined factors associated with treatment response after an 8-week sofosbuvir-based therapy and developed a simple model to predict an individual's likelihood of treatment success.
No takes yet. Share an insight, caveat, or question.
OʼBrien et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: